Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic study of serelaxin on left ventricular function in acute heart failure
2013-005054-30Phase 3Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in Acute Heart Failure (AHF) comparing Serelaxin with Control (standard of care) (2 arms). Primary endpoint: Change in LVESVi by CMR at 6 months. Started Mar 2014; status: terminated.
02
Drugs
serelaxin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2013-005054-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005054-30.